NCT01608230
Completed
N/A
Human Tumor Sequencing Project
Scripps Translational Science Institute1 site in 1 country35 target enrollmentApril 2010
ConditionsCancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Scripps Translational Science Institute
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- Determine biomarkers of clinical utility and copy number variants through genetic analysis.
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.
Investigators
Eric Topol, MD
Director
Scripps Translational Science Institute
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of a solid tumor or blood borne cancer
- •18 years or older
- •Eligible to have blood drawn
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Determine biomarkers of clinical utility and copy number variants through genetic analysis.
Time Frame: four years
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Genome Sequencing of Human Cancer TissuesCancerNCT02105545New Mexico Cancer Research Alliance250
Completed
N/A
Feasibility Clinical Study of Targeted and Genome-Wide SequencingSolid TumorsNCT01345513University Health Network, Toronto50
Recruiting
N/A
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramGliomaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMelanomaSarcomaNCT01772771M.D. Anderson Cancer Center12,000
Unknown
N/A
Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor SpecimensSequence AnalysisNCT03719222ACT Genomics600
Suspended
N/A
Upper GI Serial Tumour BiopsiesOesophageal CancerGastric CancerNCT05233007The Christie NHS Foundation Trust300